BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28215459)

  • 1. Leptomeningeal metastases presenting exclusively with ocular disturbance in 34 patients: A tertiary care cancer hospital experience.
    Mayer RR; Frankfort BJ; Strickland BA; Debnam JM; McCutcheon IE; Groves MD; Weinberg JS
    J Clin Neurosci; 2017 May; 39():151-154. PubMed ID: 28215459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular symptoms secondary to meningeal carcinomatosis in a patient with lung adenocarcinoma: a case report.
    Sabater AL; Sadaba LM; de Nova E
    BMC Ophthalmol; 2012 Dec; 12():65. PubMed ID: 23249254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
    Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
    Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most common sites on MRI of intracranial neoplastic leptomeningeal disease.
    Debnam JM; Mayer RR; Chi TL; Ketonen L; Weinberg JS; Wei W; Groves MD; Guha-Thakurta N
    J Clin Neurosci; 2017 Nov; 45():252-256. PubMed ID: 28802798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
    Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losing all sense: a case of meningeal carcinomatosis.
    Kirthi V; Penn H; Hamdulay S; Ranger A; Higgens C
    BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22699476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular manifestations of meningeal carcinomatosis: a case report and literature review.
    Walz J
    Optometry; 2011 Jul; 82(7):408-12. PubMed ID: 21501975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
    Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
    Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
    Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
    J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy for leptomeningeal disease in breast cancer.
    Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
    Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure prevalence, contributing factors, and prognostic factors in patients with leptomeningeal disease.
    Zima LA; Tulpule S; Samson K; Shonka N
    J Neurol Sci; 2019 Aug; 403():19-23. PubMed ID: 31176194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Window to the Brain: Neuro-Ophthalmology for the Primary Care Practitioner.
    Prasad S
    Am J Med; 2018 Feb; 131(2):120-128. PubMed ID: 29079403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report.
    Glitza IC; Haymaker C; Bernatchez C; Vence L; Rohlfs M; Richard J; Lacey C; Mansaray R; Fulbright OJ; Ramachandran R; Toth C; Wardell S; Patel SP; Woodman SE; Hwu WJ; Radvanyi LG; Davies MA; Papadopoulos NE; Hwu P
    Cancer Immunol Res; 2015 Nov; 3(11):1201-6. PubMed ID: 26216417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptomeningeal disease.
    Groves MD
    Neurosurg Clin N Am; 2011 Jan; 22(1):67-78, vii. PubMed ID: 21109151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuro-ophthalmic sarcoidosis: the University of Iowa experience.
    Koczman JJ; Rouleau J; Gaunt M; Kardon RH; Wall M; Lee AG
    Semin Ophthalmol; 2008; 23(3):157-68. PubMed ID: 18432542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptomeningeal carcinomatosis as primary presentation of metastatic urothelial cancer.
    Lambird J; Beerepoot L
    BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic breast cancer presenting as sequential cranial nerve palsy: a case report.
    Madgula IM; Hemmerdinger CM; Clark P
    J Med Case Rep; 2014 Dec; 8():430. PubMed ID: 25511612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charles Bonnet syndrome as a manifestation of leptomeningeal metastases.
    Rashid A; Valentine AD
    Psychosomatics; 2010; 51(5):447. PubMed ID: 20833946
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials.
    Buszek SM; Chung C
    Front Oncol; 2019; 9():1224. PubMed ID: 31803614
    [No Abstract]   [Full Text] [Related]  

  • 20. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
    Jung TY; Chung WK; Oh IJ
    Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.